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Abstract 
The aim of this study was to develop and evaluate a screening tool for people with diabetes at 
increased risk of medicine-related problems. A retrospective audit was undertaken of all 
attendances to a diabetes outpatient clinic at a public, teaching hospital over a 16-month 
period. Logistic regression was used to examine the risk factors associated with medicine-
related problems, and to compile the most predictive set of factors for developing the 
Diabetes Medication Risk Screening Tool (N=965). To evaluate the tool, the sensitivity, 
specificity, positive and negative predictive values, cut-off scores, inter-rater reliability, and 
content validity were assessed. The tool comprises seven predictive factors: age, living alone, 
prefers English language, mental and behavioural conditions, comorbidity index score, 
number of prescribed medicines, and number of prescribed high-risk medicines. Due to the 
tool’s good psychometrics properties, it can be used by nurses to proactively identifying 
people at greatest risk of experiencing medicine-related problems. 
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Diabetes is primarily managed in the community by individuals who have to follow a 
complex medication regimen comprising a number of medications, as well as to adhere to an 
appropriate diet and exercise regimen (American Diabetes Association, 2013). The process of 
self-care in managing diabetes is particularly challenging for people. Following a complex 
treatment regimen can be difficult especially since individuals have to consult with several 
different health care professionals, including nurses, dieticians, podiatrists, pharmacists, 
endocrinologists and diabetic educators (Diabetes Australia, 2013). In addition, people with 
diabetes (PWD) are often confronted by other factors that can impact on their ability to 
manage their diabetes. Such factors include: older age (Gambert & Pinkstaff, 2006), ethnicity 
and language (Yang et al., 2009), living alone (Leendertse, Egberts, Stoker, & van den Bemt, 
2008), cognitive impairment (Stilley, Bender, Dunbar-Jacob, Sereika, & Ryan, 2010), 
impaired vision (Odegard & Gray, 2008), and poor medication knowledge (Cumbler, Wald, 
& Kutner, 2010).  
Background 
Screening tools can be an efficient way to help to identify people at increased risk of health 
problems (Berg & Norman, 1996). Currently, there is no systematic or objective way to 
determine people at most risk of medicine-related problems. A small number of risk 
screening tools for medicine-related problems were identified in the literature (Fuller & 
Watson, 2005; Gordon, Smith, & Dhillon, 2005; Isaksen et al., 1999; Johnson, Nye, Hill-
Besinque, & Cody, 1995; Koecheler, Abramowitz, Swim, & Daniels, 1989; Langford, 
Jorgenson, Kwan, & Papoushek, 2006; Levy, 2003; Morisky, Green, & Levine, 1986; 
Svarstad, Chewning, Sleath, & Claesson, 1999). However, there are limitations in their 
development or use, which raises questions about their validity, reliability, applicability, or 
generalisability. In particular, certain high risk population groups were excluded in during the 
                                                                                      
development of  most screening tools (Langford et al., 2006; Levy, 2003) such as people who 
do not speak English (Langford et al., 2006), who are cognitively impaired (Langford et al., 
2006; Levy, 2003) or who are illiterate, blind, or have mental and behavioural conditions 
(Levy, 2003). These population groups has been shown to be strongly at risk of problems 
associated with medicine-related problems (Ciechanowski, Katon, & Russo, 2000; Cohen, 
1999; DiMatteo, Lepper, & Croghan, 2000; Donnan, MacDonald, Morris, & DARTS/MEMO 
Collaboration, 2002; Gazmararian et al., 2006; Houston-Miller, Hill, Kottke, Ockene, & the 
Expert Panel on Compliance, 1997; Mackin & Arean, 2007; MacLaughlin et al., 2005; 
Persell, Osborn, Richard, Skripkauskas, & Wolf, 2007; Yamada et al., 2006). Additionally, 
selection bias can impact on validity and the ability to generalise findings, as shown by the 
studies undertaken by Isaksen et al. (1999) and Morisky et al. (1986) who had samples 
comprising 91% African Americans, and 93.3% men respectively. Only three studies 
identified provided power calculations to justify their sample size (Isaksen et al., 1999; 
Johnson et al., 1995; Langford et al., 2006).  
The objective of this study was to develop a reliable, valid, objective screening tool for 
PWD who are at most risk of medicine-related problems. Medicine-related problems were 
defined for the current study as situations when the medications were not being taken as 
prescribed or when the PWD experienced an adverse event associated with their medications. 
Methods 
Design 
A retrospective medical record audit were undertaken to quantify the relationship between 
medicine-related problems experienced by PWD in an outpatient setting and the current 
literature for risk factors. The study hospital was an adult teaching public hospital with a 
capacity of 380 beds, providing an extensive range of health services to a diverse population. 
                                                                                      
The Human Research Ethics Committee of the study hospital and of the collaborating 
university approved the study.  
Data Collection 
Identification of risk factors. The audit included all PWD attending a specialist diabetes 
outpatient clinic over a 16-month period. The data were compiled from the Health 
Information Services (HIS) database and the paper medical health record. The HIS database 
was electronically examined by one reviewer to identify all PWD who attended the diabetes 
outpatient clinic from 1 January 2005 until 30 April 2006. An outpatient attendance was 
recorded any time that a person was assessed by a medical practitioner in the diabetes 
outpatient clinic. Information collected from the HIS database included demographic and 
outpatient attendance-related data. In addition, an in-depth review of the paper medical health 
record was conducted by the same reviewer to collect further information about an 
individual’s health management. Details about many biological and physical markers were 
collected, for example, HbA1c   and blood glucose levels. The dichotomous variable 
‘medicine-related problem’ was recorded as yes if the person involved met any of the 
following criteria: taking too much medication; taking too little medication, not taking any 
medication; and experiencing recurrent hypoglycaemia. If there was no documentation of a 
medicine-related problem, the reviewer documented that the person did not experience a 
medicine-related problem.  
The Australian modified version of the International Classification of Diseases (ICD), 
10
th
 revision (ICD-10-AM) was used to classify patient circumstances influencing their 
outpatient clinic attendances (World Health Organisation, 2000). The ICD-10-AM code set 
was used to assign diagnosis codes to the data associated with outpatient attendances. This 
process enabled the codes to be systematically and objectively applied. 
                                                                                      
Individuals’ linguistic background was defined as being either from a non-English 
speaking background (NESB) or from an English speaking background (ESB). People born 
in a non-English speaking country (NESC), who preferred a language other than English, or 
needed an interpreter was defined as NESB.  
The Australian Medicines Handbook (AMH) (2007) was used to categorise individuals’ 
prescribed medications: in all, 19 specific medication groups were categorised. High-risk 
medications were categorised using an internationally recognised list of high-risk medications 
(Institute for Safe Medication Practices, 2008).  
The Charlson Comorbidity Index Score (CCI) (Charlson, Pompei, Ales, & Mackenzie, 
1987) was used to calculate disease burden and to quantify individuals level of comorbidity. 
The CCI was originally modified to the ICD version 9 code set (Deyo, Cherkin, & Ciol, 
1992) and has since been integrated in the Australian ICD code set (Sundararajan et al., 
2004).  
The Socioeconomic Indexes for Areas (SEIFA) Advantage/Disadvantage Index was used 
to measure the social and economic wellbeing of different areas in Australia. SEIFA scores 
were calculated by grouping individual’s Australian postcodes into quintiles (Australian 
Bureau of Statistics, 2001).  
From an examination of current literature and from the preliminary analysis, 21 risk 
factors were identified. To ascertain the best set of risk factors for predicting medicine-related 
problems in PWD, regression analysis was conducted; the final set of risk factors comprised 
the screening tool. The psychometric properties of the resultant Diabetes Medication Risk 
Screening Tool (DMRST) including its sensitivity, specificity, predictive efficiency, cut-off 
score, inter-rater reliability, and content validity were examined. 
Sensitivity, specificity, and predictive indices. Accuracy of the tool to detect an 
individual’s likelihood of having a medicine-related problem was measured by calculating 
                                                                                      
the sensitivity and specificity. The precision of the tool relating to the likelihood that a 
positive or negative value was the true value was measured using PPV and NPV. 
Scoring of the tool. The beta coefficient of each of the seven variables in the final 
regression analysis was multiplied by 10 and rounded to the nearest whole number to score 
each item on the DMRST. This method allowed each of the seven variables to have a whole 
number assigned to it, and weighted according to its contribution to the final predictive model 
(Streiner & Norman, 2008).  
To interpret the risk score, a cut-off separating low-risk from high-risk of medicine-
related problems was established, which was based on the most optimal sensitivity and 
specificity. A receiver operating characteristic (ROC) curve was created by plotting the 
sensitivity on the y-axis against 1 - specificity on the x-axis, representing each cut-off points 
(Bewick, Cheek, & Ball, 2004). In addition to generating a ROC curve, the ability of the 
DMRST was also measured by determining the area under the ROC (AUROC) curve. An 
AUROC of 1 indicates an ideal tool, whereas an AUROC of 0.5 would be due to chance 
(Bewick et al., 2004). 
Inter-rater reliability. Inter-rater reliability was undertaken by calculating the 
agreement among 17 different raters who assessed 14 different case scenarios using the 
newly developed DMRST. The case scenarios were developed from individual patient cases 
selected from the outpatient data. After stratifying the sample into two groups (low and high-
risk) established by the selected cut-off score, cases were randomly selected from each group, 
with the final selection comprising eight high-risk and six low-risk case scenarios. A short 
monologue was developed for each case scenario. The monologue incorporated all facts 
relevant to assessing the individual’s risk of having a medicine-related problem. Postgraduate 
emergency nursing students, diabetes educators and outpatient clinic nurses were invited to 
participate in the inter-rater reliability testing procedure.  
                                                                                      
Content validity. Content validity of the DMRST was assessed by eight health experts 
using the Content Validity Rating Survey (Grant & Davis, 1997). The experts comprised of 
nurses, doctors, and pharmacists, from backgrounds including university teaching in nursing 
(n = 4), tool construction and evaluation (n = 2), medication safety (n = 1), and clinical 
pharmacology (n = 1). The survey comprised three sub-scales: item content; item style; and 
item comprehensiveness. The final draft of the DMRST and the Content Validity Survey 
were distributed to panel experts. Each panel expert independently examined the DMRST at 
both an item level and as a whole tool and provided a score at each of these levels.  
Analysis 
The Statistical Package for the Social Sciences (SPSS), version 15 (SPSS Inc., 2005) was 
used to analyse data. The Chi-square test for independence (  2) was used for the univariate 
analysis to identify categorical variables (likely risk factors) that had an independent 
significant relationship with a medicine-related problem. The Fisher’s exact test was used if 
there was a frequency of less than five within a particular cell point (Petrie & Sabin, 2005). 
To interpret the Chi-square statistic with only two dichotomous variables, Yates' Correction 
for Continuity was used to allow for the inflation of the Chi-square (Pallant, 2005). The size 
of the sub-groups within each variable was also assessed at this stage, and if the sub-groups 
were too small, they were collapsed into larger sub-groups to achieve adequate group sizes of 
at least 40. 
A number of assumptions were checked before undertaking logistic regression analysis, 
which included having an adequate sample size, multicollinearity, the absence of outliers, and 
the goodness of fit to the model (Pallant, 2005). A direct logistic regression was conducted to 
identify predictive factors associated with a medicine-related problem. This method was 
chosen to analyse the data because all predictors (variables) enter the equation 
simultaneously, which is the preferred method of logistic regression when there is no order of 
                                                                                      
importance in the independent variables (Tabachnick & Fidell, 2007). The DMRST was then 
composed from the set of factors, which constituted the most predictive logistic regression 
model. 
Fleiss’ Kappa coefficient (Fleiss, 1971) was calculated to determine the inter-rater 
reliability of the DMRST. To interpret the kappa statistic the following range of values was 
used. For values from 0.00 to 0.20, this involved poor agreement; from 0.21 to 0.40 this 
involved fair agreement; from 0.41 to 0.60 this involved moderate agreement; from 0.61 to 
0.80 this involved substantial agreement; and from 0.81 to 1.00, this involved almost perfect 
agreement (Landis & Koch, 1977). 
Content validity of the DMRST was measured using the Index of Content Validity (CVI) 
method (Waltz & Bausell, 1981; Waltz, Strickland, & Lenz, 1984). The CVI uses a four-
point ordinal rating scale, where 1 represents not relevant and 4 represents very relevant. 
Every item is then rated on three sub-scales comprising representativeness, clarity, and 
comprehensiveness, and on the scale as a whole (Waltz & Bausell, 1981; Waltz et al., 1984). 
A CVI value of greater than 0.80 at the item or scale level is considered acceptable (Davis, 
1992). 
Results 
Demographic and Medication Characteristics 
A total of 1,081 PWD attended the study hospital diabetes outpatient clinic between 1 
January 2005 and 30 April 2006; 116 people were excluded due to leaving the appointment 
prior to being reviewed by a healthcare provider. Final analysis was conducted on 965 
individuals. Demographic characteristics of the 965 individuals are shown in Table 1.  
Most individuals came from a NESB (n = 655, 67.9%), with 65 different countries of 
birth documented. Most were born in Italy (n = 161, 24.8%) or Greece (n = 109, 16.8%). The 
majority of the 310 people from an ESB (n = 283, 89.6%) were born in Australia. Of the 965 
                                                                                      
individuals who attended the diabetes outpatient clinic, 354 (36.7%) people had a preferred 
language other than English: 23 different languages were documented. In all, 90% (n = 
319/354) of people with a preferred language other than English, required an interpreter.  
Chi-squares statistics demonstrated a significant difference between people from an ESB 
and a NESB attending the diabetes outpatient clinic. People from a NESB were more likely to 
be women, older (M = 69.0 years, SD = 11.3 vs. M = 62.2 years, SD = 15.3), married, hold 
religious beliefs, and come from a more advantaged socioeconomic group.  
Type 2 diabetes accounted for the majority of the sample (n = 900, 93.3%).  More than 
half of these people required insulin therapy (53.0%). HbA1c levels ranged between 5.0% and 
16.4% (M = 8.02, SD = 1.52): 559 (62.0%) were above the desirable reference range of 
≤7.0% (Australia & Practitioners, 2009). A total of 423 (43.8%) people had microvascular 
complications. The most prevalent microvascular complication was retinopathy (25.8%), but 
almost as many people had nephropathy (25.2%). Very few people had peripheral neuropathy 
(0.8%). Eighty two per cent (791) of people experienced macrovascular complications; the 
most prevalent complication was coronary heart disease (79.7%). Few people had cerebral 
vascular or peripheral vascular complications (7.3% and 1.0% respectively).  
Hypertension was the most frequently documented comorbidity, accounting for 
almost three-quarters of the study sample (72.8%). Three-fifths of the total study population 
had dyslipidaemia (62.1%), and almost half were obese, defined as a BMI ≥ 30 (46.7%). 
Almost all people with type 2 diabetes were obese (n = 428, 94.9%) with a BMI ranging from 
30.01 to 68.97 (M = 36.12, SD = 5.74). Additionally, only a small number of people reported 
cognitive or hearing impairment, or consuming excessive amounts of alcohol or illicit drugs. 
NESB people were also significantly less likely to have mental and behavioural conditions, 
live alone, be a smoker, use alcohol excessively, or use illicit drugs. Cognitive, visual, and 
hearing impairment were equally distributed between both groups. 
                                                                                      
The 965 individuals collectively were prescribed 6,261 different medications grouped 
into 19 different categories: the number of medications prescribed was between 1and 22 (M = 
6.49, SD = 3.24), and individuals used between 1 and 29 doses per day (M = 8.19, SD = 
4.28). These statistics do not include medications taken ‘as needed’ (pro re nata - PRN) or 
medications given weekly, monthly or less frequent doses.  
The most frequently prescribed medications were from the endocrine and metabolic 
group (37.8%), which included glucose lowering medications (oral agents and insulin). 
Cardiovascular medications were prescribed almost as frequently (36.9%). Almost 10% of 
people were prescribed blood and electrolyte medications, which included warfarin (a high-
risk medication). During the 16-month study period, 262 (27.2%) people were prescribed at 
least one new medication by their diabetes specialist. Another 77 (8.0%) people had two new 
medications prescribed, and 25 (2.6%) had between three and six new medications 
prescribed. Of note, these data only include prescribing by hospital specialists, not by general 
practitioners in the community. Moreover, 588 (60.9%) individuals had changes to their 
medication doses; the number of dose changes ranged from 1 to 14 (M = 2.06, SD = 1.29) for 
each individual over the 16-month period.  
Almost one-third of the 6,261 medications prescribed (n = 1,836, 29.3%) were classified 
as high-risk medications (HRM) according to an internationally accepted list of HRMs 
(Institute for Safe Medication Practices, 2008). Furthermore, 97.0% (n = 936) of the 965 
people were prescribed at least one HRM; each person was prescribed between one and five 
(M = 1.96, SD = 0.78) HRMs. The vast majority (n = 1,723, 93.8%) of HRMs were oral 
glucose lowering medications or insulin. Warfarin accounted for 2.6% (n = 47) of HRMs, 
chemotherapy medications accounted for 2.1% (n = 38) and opiate analgesics accounted for 
1.5% (n = 28).  
                                                                                      
A total of 150 medication allergies were recorded for 114 people (11.8%). Anti-infective 
medications was the most common medication category associated with allergy, and 
penicillin accounted for the majority of allergies (n = 48/57; 84.2%). Since documentation of 
an allergy may not have indicated a recent medication event or may not have been directly 
associated with a medication, allergies were not considered to be a medicine-related problem 
for the purpose of analysis. 
More than half (n = 540, 56.0%) of the sample experienced at one or more medicine-
related problem during the 16-months. Two types of medicine-related problems occurred: 
hypoglycaemia (n = 104, 19.3%) and failure to take medication as prescribed (n = 436, 
80.7%). The majority (n = 411, 76.3%) had medicine-related problems recorded during at 
least one attendance and 10.2% (n = 55) had medicine-related problems recorded at two 
outpatient attendances. Medicine-related problems were documented by the health care 
provider as being due to people taking too much medication, not filling a prescription, or not 
increasing, reducing, commencing, or ceasing a medication recommended by their health care 
provider at their previous outpatient clinic appointment.  
Examination of the linguistic backgrounds showed that a third of PWD from a NESB (n 
= 231/655, 35.3%) experienced a medicine-related problem, whereas almost all PWD from 
an ESB experienced a medicine-related problem (n = 309/310, 99.7%) [χ2 (df = 1) = 353.098, 
p < .001]. Table 2 shows the characteristics of people who experienced a medicine-related 
problem. 
People who had a medicine-related problem were more likely to have type 2 diabetes 
(89.6%), be male (59.4%), and be aged over 51 years (85.7%). Chi-square statistics show a 
significant difference in all demographic variables when comparing PWD from an ESB with 
those from a NESB. People from a NESB were more likely have type 2 diabetes, be female, 
                                                                                      
be aged over 51 years, were not married and in a de-facto relationship, and came from either 
the least advantaged or the most advantaged socioeconomic area (quintile 1 or 5). 
Approximately one in nine people had an admission to the study hospital for a medicine-
related problem (n = 81/965, 8.4%). The number of admissions for a medicine-related 
problem ranged between one and four per person (M = 1.35, SD = 0.71); most had one 
admission (n = 62, 76.5%), 14.8% had two admissions, 6.2% had three admissions, and 2.5% 
had four medicine-related problem admissions. People admitted for a medicine-related 
problem tended to have type 2 diabetes and were aged 51 years or older. There was no 
difference shown between genders. 
Final Set of Risk Factors 
Individual Chi-square tests for independence (  2) were performed on 21 categorical 
variables (risk factors). Chi-square statistics and level of significance are shown in Table 3. 
Thirteen variables were significant (p < .05) in the univariate analysis; of these 10 were 
highly significant (p < .01). Before conducting the logistic regression analysis, the 13 
significant variables were assessed to ensure they met the underlying assumptions of 
adequate group size, multicollinearity, and absence of outliers. The sub-groups in one 
variable (age group) were collapsed to ensure that an adequate sample size for analysis.  
The four variables Linguistic Background, Country of Birth, Preferred Language of 
English, and Interpreter Required  had very low tolerance values (0.26, 0.27, 1.59, 1.53) and 
very high variance inflation factor (VIF) values (38.113, 37.226, 6.557, 6.289) respectively, 
these findings indicated  the presence of multicollinearity. The three variables Linguistic 
Background, Country of Birth, and Interpreter Required were removed and the analysis was 
re-run. Retaining the variable of Preferred Language of English, the resultant model had 10 
variables. For the 10 variables, the tolerance and VIF values were shown to be acceptable. 
Lastly, there were also no outliers, or missing data in the dataset.  
                                                                                      
Logistic regression analysis was used to assess the 10 variables for their association with 
a medicine-related problem in the outpatient clinic; seven variables comprised the final 
logistic regression model (Table 4). The final model displayed good fit for discrimination 
among groups, with a highly significant goodness-of-fit test [χ2 (df = 9, N = 965) = 200.012, p 
< .001]. The Nagelkerke R
2
 = .250 (95% CI .187, .250) indicated that a quarter of the 
variability was explained by the final set of seven variables (Pallant, 2005). The non-
significant Hosmer and Lemeshow goodness-of-fit test also supports the validity of the model 
[χ2 (df = 8, N = 965) = 7.416, p = .492]. 
Sensitivity, specificity, and predictive indices. The DMRST has 76.5% sensitivity and 
59.5% specificity. The aim of the tool is to predict individuals at an increased risk of a 
medicine-related problem, so a higher sensitivity is preferred (Kirkwood & Sterne, 2003; 
Petrie & Sabin, 2005). The PPV was acceptable, correctly identifying 65.1% of individuals 
who had a medicine-related problem. The NPV was more sensitive, correctly identifying 
71.8% of individuals who did not have a medicine-related problem.  
Scoring of the tool. Given the 76.5% sensitivity and 59.5% specificity from the final 
logistic regression model, a cut-off score of 27 was derived from coordinates of the ROC 
curve. However, the ROC curve also enables different sensitivity or specificity values to be 
explored and the impact it has on the cut-off score. Since a higher sensitivity is more 
desirable for the objective of the current screening tool, the ROC curve was used to 
investigate the impact of increasing the sensitivity on the specificity. For example, choosing 
to increase the sensitivity to 81.5% (an increase of 5.0%) would result in a specificity of 
54.3% (a decrease of 5.2%). Since the specificity became unacceptable at 54.3%, the original 
sensitivity, specificity, and cut-off scores were retained.  
The area under the ROC curve produced by the final logistic regression model also 
indicated the screening tool was moderately reliable at predicting people at an increased risk 
                                                                                      
of a medicine-related problem (.752, SE = .015, p < .001, 95% CI .721, .782). The beta 
coefficient for each of the seven variables (risk factors) in the final regression model 
multiplied by 10 provided a score for each risk factor present (ranging from four to fifteen) 
and a total risk (of a medicine-related problem) score was then calculated by adding the score 
for each risk factor, with a total risk score ranging from 0 to 62. 
Inter-rater reliability. The raters classified medicine-related problems into either low-
risk or high-risk (see Table 5) and the majority of case scenarios were correctly classified: 
total agreement occurred in five case scenarios. A further seven case scenarios were 
misclassified by one of the 17 raters. Case scenario number 12 performed worst of all, the 
scenario described an individual at high risk of a medicine-related problem, but four assessors 
incorrectly classified it as low risk. The proportion of agreement between the assessors is 
represented by the generalised Fleiss kappa coefficient (see Table 6). The kappa statistic for 
the DMRST was 0.79 (95% CI, .75, .84) reflecting a high degree of inter-rater reliability. 
There was almost perfect agreement for four of the seven variables: age, preferred language 
of English, living alone, and the number of prescribed medications (κ > .80). However, there 
was only fair agreement between assessors for the CCI score (κ >0.20).  
Content validity. Content validity of the DMRST was assessed by eight experts using 
the Content Validity Rating Survey (Grant & Davis, 1997). The final results are represented 
as CVI scores for each of the three sub-scales and the entire scale (see Table 7). The CVI 
scores reflected complete agreement on six items across all sub-scales. Only one expert 
considered item 5 not representative, resulting in its CVI score of 87.5%. The entire scale has 
a CVI score of 99.4%, indicating the experts agreed the DMRST had content validity.  
While none of the experts commented that anything important appeared to be missing 
from the screening tool, other issues were raised. One expert was concerned that the 
definition for mental and behavioural conditions failed to include insomnia or borderline 
                                                                                      
personality disorder. As there were no people diagnosed with insomnia or borderline 
personality disorder identified in the audit, precluding investigation of their association in the 
current research. Another expert indicated a moderate-risk group should be included when 
scoring an individual’s risk level. However, considering the purpose for which the DMRST 
was developed, it was more important to be able to stratify people into one of two groups: at 
risk, or not at risk. Therefore, a single cut-off identifying those people at risk was considered 
most desirable. 
Structure of the tool. The DMRST (Figure 1) consists of seven items (risk factors). Six 
items are dichotomous; the remaining item is polytomous. Each item receives a score based 
on the response category. Definitions are provided as part of the tool. A total risk score of 
less than 26 reflects a low risk of a medicine-related problem; a score of at least 27 indicates 
that the person is at high risk of a medicine-related problem.  
Discussion 
Seven factors were identified as significant predictors of a medicine-related problem. People 
aged between 18 and 50 years, who lived alone, with mental and behavioural conditions, a 
preferred language of English, and a high CCI score of four or more, prescribed between one 
and three medications, and prescribed two or more high-risk medications were at most risk of 
having a medicine-related problem. The final logistic model produced 76.5% sensitivity and 
59.5% specificity. A cut-off score of 27 was derived from coordinates of the ROC curve.  
Examining the effect of linguistic background on the risk of medicine-related problems 
revealed an unexpected finding. Counter to previous research (Kaplan et al., 2004; Mullins, 
2008; Yang et al., 2009), the current findings challenge the belief that people from a NESB 
are at most risk of medicine-related problems. People from an ESB were actually at an 
increased risk of medicine-related problems in the outpatient clinic setting. This finding 
                                                                                      
possibly demonstrates that all PWD, regardless of linguistic background, need support to 
safely manage their medications through education and interventions.  
The tool demonstrates that the number of high risk medications that people are 
prescribed needs to be considered, rather than the total number of medications prescribed. 
Medications with a narrow therapeutic index were far more likely to lead to a medicine-
related problem than those with a wide therapeutic index. Future research should focus on 
this important factor in examining the effect on medicine-related problems. This is especially 
an issue in PWD who are often prescribed two or more high risk medications.  
When comparing the DMRST developed for this study to the nine screening tools 
identified in the literature (Fuller & Watson, 2005; Gordon et al., 2005; Isaksen et al., 1999; 
Johnson et al., 1995; Koecheler et al., 1989; Langford et al., 2006; Levy, 2003; Morisky et 
al., 1986; Svarstad et al., 1999), the tool demonstrated it was psychometrically robust. When 
comparing the DMRST to the four tools that reported sensitivity and specificity, the 
DMRST’s properties were poorer than both Gordon et al.’s (2005) and Isaksen et al.’s (1999) 
tools. However, low reliability or selection bias was a limitation associated with these studies. 
Although the Morisky Adherence Scale (Morisky et al., 1986) had high sensitivity (81.0%), it 
had poor specificity (44.0%) resulting in a possible increase of false positives. A comparison 
to the Brief Medication Questionnaire (Svarstad et al., 1999) was difficult as these sensitivity 
and specificity properties were only provided for each sub-domain, and not to the tool as a 
whole. To interpret a screening tool, a cut-off score is required in order to stratify people into 
high and low risk. However, only three of the tools (Isaksen et al., 1999; Langford et al., 
2006; Morisky et al., 1986) provided a cut-off score, making it difficult to know how to 
interpret the results of the remaining six tools. Overall, in comparing the DMRST to the nine 
screening tools, the DMRST had a more systematic approach to development and good 
psychometric properties.  
                                                                                      
Implications for nursing practice  
Nurses commonly make decisions about the potential of medicine-related problems using 
their own perceptions of people’s experiences. Use of an objective tool such as the DMRST 
can help to provide a more objective means of determining problems. The tool could be 
implemented during outpatient appointments by nurses to pre-empt any potential concerns. 
Nurses will then be in a better position to strategically address these concerns before they 
become major adverse events.  
Limitations 
There were various limitations associated with the study. It is possible that medical record 
data that were relevant to the study were not accessible or were incorrect. The study was only 
conducted at one site, however to improve the validity and generalisability of the findings 
conducting future research at a number of sites would be recommended. The development 
and testing of the risk screening tool were undertaken using the same dataset, further 
validation work of the tool should involve testing it using an alternative dataset.  
Conclusion 
The DMRST was developed using an evidence-based methodology and was shown to be 
psychometrically valid and reliable. The DMRST has significant utility for identifying people 
at increased risk of poor management of their medications. Further testing of the tool is 
needed in a variety of outpatient departments to ensure its applicability across diverse 
environments. Ultimately, following further testing, the tool could be instrumental in 
reducing the occurrence of medicine-related problems, and therefore improving the health of 
PWD. 
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Table 1  
Demographic Characteristics of People with Diabetes who Attended the Outpatient Clinic from 1 
January 2005 to 30 April 2006 (N = 965) 
Factor                    n  % 
Gender   
 Male 537 55.6 
 Female 428 44.4 
Age Group (years)   
 18-30  16 1.7 
 31-40  30 3.1 
 41-50  58 6.0 
 51-60  164 17.0 
 61-70  243 25.2 
 71-80  350 36.3 
 ≥ 81  104 10.8 
Marital Status
 
   
 Married / de-facto 567 58.8 
 Other  398 41.2 
Religious Belief
 
  
 Yes  831 86.1 
 No  134 13.9 
Country of Birth  
 English Speaking Country 310 32.1 
 Non- English Speaking Country  655 67.9 
Interpreter Required  
 Yes  323 33.5 
 No 642 66.5 
Socioeconomic Index for Area
 
  
 First quintile 70 7.3 
 Second quintile 77 8.0 
 Third quintile 64 6.6 
 Fourth quintile 179 18.5 
                                                                                      
 Fifth quintile 575 59.6 
 
                                                                                      
 
Table 2  
Demographic Characteristics of People with Diabetes who Attended the Outpatient Clinic who had a 
Medicine-Related Problem (N = 540) 
Factor                    n  % 
Diabetes Type   
 Type 1 diabetes 56 10.4 
 Type 2 diabetes 484 89.6 
Gender   
 Male   320 59.4 
 Female 220 40.6 
Age Group (years)   
 18-50  77 14.3 
 ≥ 51 463 85.7 
Marital Status
 
   
 Married / de-facto 267 49.4 
 Other  273 50.6 
Socioeconomic Index for Area
 
  
 First quintile 38 7.0 
 Second quintile 46 8.5 
 Third quintile 39 7.2 
 Fourth quintile 108 20.0 
 Fifth quintile 309 57.2 
 
 
 
  
                                                                                      
 
Table 3  
Univariate Analysis of Factors Associated with Medicine-Related Problems in the Outpatient Clinic 
(N = 965) 
Factor 
2
 
 Linguistic background 351.599**
b
 
 Country of birth 351.432**
c
 
 Preferred language other than English 87.678**
b
 
 Interpreter required  66.280**
b 
 
 Lives alone   36.372**
b
 
 Marital status 33.265**
b
 
 Diabetes type  24.487**
b
 
 Age group (≥ 51) 14.649**b 
 Comorbidity index score                                  16.139** 
 Number of high-risk medications                                 9.251* 
 Mental and behavioural conditions                                     8.851**
b
 
 Gender                                   6.152*
b
 
 Number of medications (≥ 4)                                  3.799*b 
 Number of medication changes during study period                              13.620 
 Number of prescribers involved in person’s care (≥ 2)                                1.946b 
 HbA1c level < 7%
a
                                      0.795
b
 
 Socioeconomic status                                3.711 
 Hearing impairment                                 0.519
c
 
 Daily dose frequency                                 0.097
b
 
 Visual impairment                                 0.319
b
 
 Cognitive impairment                                 0.000
b
 
a N = 902 (ESB n = 290, NESB n = 612) as 63 records did not have data for HbA1c levels. 
b Yates’ Correction for Continuity 
used as 2 x 2 table. c Fischer’s Exact Test used as the count in at least one cell was < 5.  
*p < .05. **p < .01. 
 
 
 
                                                                                      
Table 4  
Final Logistic Regression Model for Key Factors Associated with a Medicine-Related Problem  (N = 
965) 
Independent Variable β SE 
Wald 
Statistic 
df OR 
95% CI for OR 
lower upper 
Age Group (years)        
 ≥ 51  Reference       
 18-50  0.592** .248 5.722   1 1.808   1.112 2.941 
Preferred Language        
 Not English Reference       
 English 1.485** .157 91.534 1 4.405 3.257 5.989 
Lives Alone        
 No Reference       
 Yes 1.374** .242 32.346 1 3.951 2.461 6.344 
Mental and  
Behavioural Conditions 
     
 No Reference       
 Yes 0.425* .209 4.131 1 1.530 1.015 2.306 
Charlson Comorbidity  
Index Score 
     
 0-3  Reference       
 ≥ 4 0.640** .176 13.216 1 1.897 1.343 2.678 
Number of Medications      
 ≥ 4  Reference       
 1-3  0.392* .205 3.656 1 1.479 0.990 2.212 
Number of High-risk  
Medications 
     
 0 Reference  8.771 3    
 1  1.054** .463 5.195 1 2.870 1.159 7.106 
 2-3   1.221** .458 7.111 1 3.388 1.382 8.308 
 ≥ 4  1.339** .473 8.003 1 3.814 1.509 9.640 
Constant -0.164 .508 .105 1 .849   
                                                                                      
 
Table 5  
Assessors’ Risk Classification of Case Scenarios (N = 17) 
Case 
Scenario 
Actual 
Risk 
Assessor’s Classification 
Low Risk 
(Score < 26) 
High Risk 
(Score ≥ 27) 
1 Low risk  16 1 
2 Low risk 17 0 
3 Low risk 16 1 
4 High risk  0 17 
5 High risk  1 16 
6 High risk  1 16 
7 High risk  1 16 
8 Low risk 16 1 
9 High risk 0 17 
10 High risk 0 17 
11 Low risk 17 0 
12 High risk 4 13 
13 High risk 1 16 
14 Low risk 15 2 
Note. The incorrect classifications are highlighted in shaded colour. 
                                                                                      
Table 6  
Inter-Rater Reliability of the DMRST (N = 17) 
Item      κ  
95% CI 
lower upper 
Entire Scale (all seven items combined) 0.79 0.75 0.84 
Item. 1  Age  0.98 0.93  1.02 
Item. 2  Preferred language  0.88 0.84 0.93 
Item. 3  Lives alone 0.87 0.82  0.91 
Item. 4   Mental and behavioural conditions 0.61 0.57  0.66 
Item. 5   CCI risk score  0.28 0.24  0.33 
Item. 6  Number of prescribed medications  0.86 0.81  0.90 
Item. 7  Number of high-risk medications  0.45 0.43  0.48 
 
 
 
 
                                                                                      
 
Table 7  
Content Validity Index Scores for the DMRST (N = 8) 
Item 
CVI Sub-Scale (%) Entire 
Scale Representativeness Clarity Comprehensiveness 
1  Age  100.0 100.0 100.0 100.0 
2  Preferred language  100.0 100.0 100.0 100.0 
3  Lives alone 100.0 100.0 100.0 100.0 
4   
Mental and behavioural 
conditions 
100.0 100.0 100.0 100.0 
5   CCI risk score  87.5  100.0 100.0 95.8 
6  
Number of prescribed 
medications  
100.0  100.0 100.0 100.0 
7  
Number of high-risk 
medications  
100.0  100.0 100.0 100.0 
Average CVI 98.2 100.0 100.0 99.4 
 
 
                                                                                      
 
 
 
 
 
 
 
 
 
        
Under 50 years  6      1. Age Group 
51 years and over  0      
        
Not English  0      2. Preferred Spoken Language 
English 15      
        
No  0      3. Lives Alone 
Yes 14      
        
No  0      4. Mental and Behavioural Problems 
Yes 4      
        
0-3  0    5. Charlson Comorbidity Index Score 
4 or more 6  
 
 
  
        
1-3 4    6. Number of Medications Prescribed 
4 or more 0   
 
  
        
0 0      
1 11    
2 12  
 
  
3 or more  13      
7. Number of High-Risk Medications Prescribed  
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Mental and Behavioural Problems 
Schizophrenia  
Bipolar affective Disorder  
Schizoaffective Disorder  
Depression  
If a person has one or 
more of the following, 
answer YES. 
Anxiety  
Charlson Comorbidity Index Score 
Condition Weight Score 
Myocardial infarction 1  
Congestive heart failure  1  
Peripheral vascular disease  e.g. Gangrene 1  
Cerebral vascular accident e.g. Stroke 1  
Dementia e.g. Vascular dementia, in alzheimer’s 1  
Pulmonary disease e.g. Asthma  1  
Connective tissue disorder e.g. Rheumatoid arthritis 1  
Peptic ulcer e.g. Gastric, duodenal 1  
Liver disease e.g. Cirrhosis, fibrosis, hepatitis 1  
Severe liver disease e.g. Hepatic failure 3  
Diabetes e.g. Acidosis, circulatory complication 1  
Diabetes end organ complications e.g. Renal 2  
Paraplegia e.g. Hemiplegia, paraplegic 2  
Renal disease e.g. Renal failure 2  
Cancer (localised) 2  
Metastatic cancer  3  
AIDS/HIV  6  
Assign the relevant 
weight score for each 
condition that a person 
has from any of the 17 
categories. The score is 
only assigned once for 
each category, 
regardless of the 
number of diseases. 
 
Add up the scores and 
place the total score in 
the space provided. 
For example asthma (1) 
and diabetes with 
diabetic kidney disease 
complication (2) comes 
to a total score of 3 
(1+2). 
Total Score   
High-Risk Medications 
Antidiabetic Medications: oral and subcutaneous  
e.g. metformin, protophane,  
 
Chemotherapy Medications: oral and parenteral   
e.g. tamoxifen, cyclophosphamide  
 
Narcotic/Opiate Medications: oral and transdermal   
e.g. oxycodone, tramadol, codeine 
 
Anticoagulant Medications: oral and subcutaneous  
e.g. warfarin, heparin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methotrexate: oral   
Count the number of 
high risk medications 
that a person is 
prescribed. 
Total Score  
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Figure 1. The Diabetes Medication Risk Screening Tool (DMRST) 
